Spastic Hemiplegia
Conditions
Brief summary
The aim of the study is to compare the effectiveness of the classical (2-4 points to the muscle proximal) application of botulinum toxin in the treatment of spasticity with the application along the length of the gastrecnemius muscle. The main question it aims to answer Is botulinum toxin more effective in the treatment of spasticity than the classical application applied along the length of the gastrocnemius muscle? Participants will be evaluated for spasticity before and 1 month after injection. Researchers will compare classical versus application along the length of the muscle to see if there is a reduction in spasticity.
Interventions
200iu/2ml in both groups
Sponsors
Konya Beyhekim Training and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosed with spastic hemiplegia * Spasticity in the gastrocnemius muscle
Exclusion criteria
* Those who have spasticity in other muscles that will affect ankle movements * Those who use myorelaxant or myospasm-effective drugs * Those who have been applied botulinum toxin in the last 3 months * Those who have contractures in the ankle and knee due to orthopedic reasons.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Spasticity assessment (change between pre-injection and 1-month control) | before injection and 1 month after injection | Modified ashworth scale |
| ambulation level (change between pre-injection and 1-month control) | before injection and 1 month after injection | functional ambulation scale |
| ambulation velocity (change between pre-injection and 1-month control) | before injection and 1 month after injection | preferred walking speed |
Countries
Turkey (Türkiye)
Contacts
Primary ContactSavaş Karpuz, M.D.
Outcome results
None listed